Name | Number of supported studies | Average coverage | |
|---|---|---|---|
| endothelial cell | 23 studies | 32% ± 13% | |
| astrocyte | 16 studies | 36% ± 17% | |
| oligodendrocyte | 16 studies | 62% ± 16% | |
| oligodendrocyte precursor cell | 15 studies | 42% ± 17% | |
| glutamatergic neuron | 13 studies | 52% ± 26% | |
| fibroblast | 12 studies | 28% ± 9% | |
| GABAergic neuron | 11 studies | 56% ± 23% | |
| pericyte | 11 studies | 28% ± 11% | |
| microglial cell | 11 studies | 31% ± 10% | |
| macrophage | 10 studies | 31% ± 14% | |
| epithelial cell | 9 studies | 34% ± 14% | |
| adipocyte | 9 studies | 32% ± 8% | |
| neuron | 7 studies | 47% ± 21% | |
| interneuron | 7 studies | 58% ± 23% | |
| club cell | 6 studies | 26% ± 9% | |
| dendritic cell | 6 studies | 21% ± 3% | |
| ciliated cell | 6 studies | 23% ± 6% | |
| basal cell | 6 studies | 29% ± 17% | |
| T cell | 6 studies | 22% ± 6% | |
| endothelial cell of lymphatic vessel | 6 studies | 34% ± 9% | |
| smooth muscle cell | 6 studies | 30% ± 5% | |
| amacrine cell | 5 studies | 31% ± 12% | |
| retina horizontal cell | 5 studies | 32% ± 14% | |
| cardiac muscle cell | 5 studies | 31% ± 9% | |
| mast cell | 5 studies | 26% ± 9% | |
| myeloid cell | 5 studies | 23% ± 4% | |
| monocyte | 5 studies | 24% ± 6% | |
| type I pneumocyte | 5 studies | 37% ± 9% | |
| type II pneumocyte | 5 studies | 23% ± 6% | |
| granule cell | 4 studies | 39% ± 8% | |
| B cell | 4 studies | 24% ± 8% | |
| lymphocyte | 4 studies | 28% ± 11% | |
| retinal rod cell | 4 studies | 23% ± 4% | |
| GABAergic interneuron | 3 studies | 55% ± 4% | |
| glial cell | 3 studies | 33% ± 11% | |
| progenitor cell | 3 studies | 36% ± 2% | |
| plasma cell | 3 studies | 30% ± 4% | |
| CD4-positive, alpha-beta T cell | 3 studies | 19% ± 1% | |
| GABAergic amacrine cell | 3 studies | 39% ± 8% | |
| glycinergic amacrine cell | 3 studies | 30% ± 8% | |
| retinal cone cell | 3 studies | 22% ± 6% | |
| retinal ganglion cell | 3 studies | 48% ± 13% | |
| endothelial cell of vascular tree | 3 studies | 30% ± 15% | |
| hepatocyte | 3 studies | 35% ± 14% | |
| abnormal cell | 3 studies | 32% ± 14% | |
| neural progenitor cell | 3 studies | 33% ± 11% | |
| connective tissue cell | 3 studies | 24% ± 5% | |
| ependymal cell | 3 studies | 38% ± 20% | |
| alveolar macrophage | 3 studies | 32% ± 8% | |
| capillary endothelial cell | 3 studies | 22% ± 3% | |
| natural killer cell | 3 studies | 27% ± 5% | |
| respiratory goblet cell | 3 studies | 39% ± 12% | |
| goblet cell | 3 studies | 39% ± 23% | |
| transit amplifying cell | 3 studies | 37% ± 27% | |
| mesothelial cell | 3 studies | 28% ± 5% | |
| mucus secreting cell | 3 studies | 30% ± 5% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
|---|---|---|---|---|---|---|
| esophagus | 100% | 2456.92 | 1445 / 1445 | 100% | 47.62 | 183 / 183 |
| brain | 100% | 3590.20 | 2642 / 2642 | 100% | 68.65 | 704 / 705 |
| lung | 100% | 2652.44 | 577 / 578 | 100% | 33.92 | 1155 / 1155 |
| breast | 100% | 3083.70 | 459 / 459 | 99% | 40.93 | 1112 / 1118 |
| ovary | 100% | 3010.51 | 180 / 180 | 99% | 21.87 | 427 / 430 |
| intestine | 100% | 2756.16 | 966 / 966 | 99% | 25.42 | 522 / 527 |
| bladder | 100% | 2749.43 | 21 / 21 | 99% | 25.78 | 499 / 504 |
| stomach | 100% | 1999.31 | 359 / 359 | 99% | 31.02 | 283 / 286 |
| uterus | 100% | 2815.34 | 170 / 170 | 98% | 25.24 | 448 / 459 |
| pancreas | 100% | 1827.33 | 327 / 328 | 98% | 24.90 | 174 / 178 |
| adrenal gland | 100% | 2834.81 | 258 / 258 | 97% | 20.71 | 224 / 230 |
| kidney | 100% | 2332.15 | 89 / 89 | 97% | 38.18 | 874 / 901 |
| thymus | 100% | 2954.04 | 653 / 653 | 97% | 21.91 | 586 / 605 |
| prostate | 100% | 2315.34 | 245 / 245 | 96% | 22.45 | 483 / 502 |
| skin | 100% | 3810.38 | 1809 / 1809 | 93% | 28.61 | 438 / 472 |
| liver | 99% | 1018.03 | 224 / 226 | 66% | 9.29 | 267 / 406 |
| adipose | 100% | 3230.17 | 1204 / 1204 | 0% | 0 | 0 / 0 |
| blood vessel | 100% | 3404.88 | 1335 / 1335 | 0% | 0 | 0 / 0 |
| spleen | 100% | 2587.21 | 241 / 241 | 0% | 0 | 0 / 0 |
| ureter | 0% | 0 | 0 / 0 | 100% | 7.48 | 1 / 1 |
| muscle | 99% | 1361.89 | 798 / 803 | 0% | 0 | 0 / 0 |
| tonsil | 0% | 0 | 0 / 0 | 96% | 25.11 | 43 / 45 |
| heart | 94% | 1514.11 | 810 / 861 | 0% | 0 | 0 / 0 |
| lymph node | 0% | 0 | 0 / 0 | 83% | 15.40 | 24 / 29 |
| eye | 0% | 0 | 0 / 0 | 60% | 8.53 | 48 / 80 |
| peripheral blood | 56% | 1904.19 | 524 / 929 | 0% | 0 | 0 / 0 |
| abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
| GO_0006511 | Biological process | ubiquitin-dependent protein catabolic process |
| GO_0000209 | Biological process | protein polyubiquitination |
| GO_0000151 | Cellular component | ubiquitin ligase complex |
| GO_0005737 | Cellular component | cytoplasm |
| GO_0061630 | Molecular function | ubiquitin protein ligase activity |
| GO_0005515 | Molecular function | protein binding |
| GO_0008270 | Molecular function | zinc ion binding |
| GO_0031624 | Molecular function | ubiquitin conjugating enzyme binding |
| Gene name | ANKIB1 |
| Protein name | ANKIB1 protein Ankyrin repeat and IBR domain containing 1 Ankyrin repeat and IBR domain-containing protein 1 (EC 2.3.2.31) RBR-type E3 ubiquitin transferase (EC 2.3.2.31) |
| Synonyms | KIAA1386 |
| Description | FUNCTION: Might act as an E3 ubiquitin-protein ligase, or as part of E3 complex, which accepts ubiquitin from specific E2 ubiquitin-conjugating enzymes and then transfers it to substrates. . |
| Accessions | ENST00000422095.1 ENST00000413588.1 ENST00000442183.1 C9JZ63 Q9P2G1 H7C2L9 ENST00000265742.8 Q58F08 Q4VBX8 ENST00000439883.1 H7C0S0 H7C2V2 |